Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study

Ana Souto-García1 Molecular Epidemiolgy of Cancer Unit, University Institute of Oncology, University of Oviedo, Oviedo, Asturias, Spain;2 Consortium for Research in Epidemiology and Public Health (CIBERESP), SpainCorrespondence[email protected]

Ana Fernández-Somoano1 Molecular Epidemiolgy of Cancer Unit, University Institute of Oncology, University of Oviedo, Oviedo, Asturias, Spain;2 Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain

Teresa Pascual3 Pneumology Department, Cabueñes Hospital, Gijón, Asturias, Spain

Sara M Álvarez-Avellón1 Molecular Epidemiolgy of Cancer Unit, University Institute of Oncology, University of Oviedo, Oviedo, Asturias, Spain;2 Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain

Adonina Tardón1 Molecular Epidemiolgy of Cancer Unit, University Institute of Oncology, University of Oviedo, Oviedo, Asturias, Spain;2 Consortium for Research in Epidemiology and Public Health (CIBERESP), Spain

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date